PT  - JOURNAL ARTICLE
AU  - Yuanqing Zhao
AU  - Jialiang Guo
AU  - Yongtuan Li
TI  - Clinical Research of a Modified Midfacial Degloving in a Maxillectomy (with a Report of a Typical Case)
AID  - 10.1007/s11805-008-0191-3
DP  - 2008 Jun 01
TA  - Chinese Journal of Clinical Oncology
PG  - 191--194
VI  - 5
IP  - 3
4099  - http://www.cancerbiomed.org/content/5/3/191.short
4100  - http://www.cancerbiomed.org/content/5/3/191.full
SO  - Cancer Biol Med2008 Jun 01; 5
AB  - OBJECTIVE To investigate the feasibility of employing a modified midfacial degloving in maxillectomy.METHODS Eight patients with carcinoma of the maxillary sinus underwent a modified midfacial degloving operation. The tumors were classified according to the 2002 AJCC system. The TNM staging of the cases was as follows: 1 T4aN0M0, 2 T3N0M0 and 5 T2N0M0. Of the 8 cases, 1 patient underwent extended maxillectomy; exenteration of the orbit; tumorectomy of the sphenomaxillary and infratemporal fossae. Two patients received a total maxillectomy, and 5 a partial resection of the maxilla. Postoperative pathological report: 4 well-differentiated squamous carcinoma, 2 moderately-differentiated squamous carcinoma, 1 mucoepidermoid carcinoma and 1 adenoid cystic carcinoma.RESULTS A modified midfacial degloving operation can sufficiently expose a field of operation, resect the tumor within a safe margin, and leave no facial cicatricles. One patient died of intracranial metastasis 8 months after operation. We observed no recurrences or metastasis in other patients during the period of follow-up.CONCLUSION The major advantages of employing the modified midfacial degloving in maxillectomy is that a facial incision can be avoided. It has an advantage of minimal invasive surgery.